Gender Has a Small but Statistically Significant Effect on Clearance of CYP3A Substrate Drugs

被引:86
作者
Greenblatt, David J. [1 ]
von Moltke, Lisa L.
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
关键词
Gender effects; cytochrome P4503A; benzodiazepines;
D O I
10.1177/0091270008323754
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of gender on the disposition of drugs metabolized by cytochrome P4503A (CYP3A) remains controversial. Some sources suggest that CYP3A activity in women exceeds that in men, but evidence to support this position is inconsistent at best. We evaluated 38 data sets in which clearance of CYP3A substrate drugs was studied in healthy young male and young female subjects. None of these drugs was a substrate for transport by P-glycoprotein (P-gp). The overall mean ( SE) for the female/male ratio of weight-normalized clearance was 1.26 (+/- 0.07) for parenteral dosage and 1.17 (+/- 0.07) for oral dosage. Both ratios were significantly different (P <.05) from 1.0. For oral dosage studies, the female/male clearance ratio was unrelated to the drug's absolute oral bioavailability Thus gender has a small and statistically significant, although most likely clinically unimportant, influence on CYP3A phenotype for substrates not transported by P-gp.
引用
收藏
页码:1350 / 1355
页数:6
相关论文
共 42 条
[1]   Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics [J].
Anderson, GD .
JOURNAL OF WOMENS HEALTH, 2005, 14 (01) :19-29
[2]   Bioequivalence revisited: Influence of age and sex on CYP enzymes [J].
Bebia, Z ;
Buch, SC ;
Wilson, JW ;
Frye, RF ;
Romkes, M ;
Cecchetti, A ;
Chaves-Gnecco, D ;
Branch, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (06) :618-627
[3]  
Beierle I, 1999, INT J CLIN PHARM TH, V37, P529
[4]   Cytochrome P450 3A and their regulation [J].
Burk, O ;
Wojnowski, L .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) :105-124
[5]   Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: Focus on dosing regimen, dosage form, and formulation [J].
Chen, ML .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) :322-329
[6]   Drugs and sex differences: a review of drugs relating to anaesthesia [J].
Ciccone, GK ;
Holdcroft, A .
BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 (02) :255-265
[7]   The influence of age and sex on the clearance of cytochrome P450 3A substrates [J].
Cotreau, MM ;
von Moltke, LL ;
Greenblatt, DJ .
CLINICAL PHARMACOKINETICS, 2005, 44 (01) :33-60
[8]   Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein [J].
Cummins, CL ;
Wu, CY ;
Benet, LZ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (05) :474-489
[9]  
DAWKINS K, 1991, PSYCHOPHARMACOL BULL, V27, P417
[10]   Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment [J].
Dorne, JLCM ;
Walton, K ;
Renwick, AG .
FOOD AND CHEMICAL TOXICOLOGY, 2003, 41 (02) :201-224